Company / R&D Expense
FEMASYS INC R&D Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$8.2M
FY2025
5-year range
$4.1M / $8.2M
FY2021-FY2025
Trend
+14.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has increased for 3 consecutive years, from $4M in FY2022 to $8M in FY2025.
Based on SEC 10-K filings.
$8M in FY2025 with a 3-year CAGR of +26.2%.
Improved from $6M to $8M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +26.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- FEMASYS INC's r&d expense has grown for 3 consecutive years.
- 3-year CAGR of +26.2%, indicating consistent growth.
- In FY2025, r&d expense increased 14.0% year-over-year.
- Lowest r&d expense in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.2M | +14.0% |
| FY2024 | $7.2M | +24.0% |
| FY2023 | $5.8M | +42.3% |
| FY2022 | $4.1M | -1.1% |
| FY2021 | $4.1M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026